Alexza Pharmaceuticals (ALXA) says the FDA has accepted a resubmitted ADASUVE New Drug...

|About: Alexza Pharmaceuticals, Inc. (ALXA)|By:, SA News Editor

Alexza Pharmaceuticals (ALXA) says the FDA has accepted a resubmitted ADASUVE New Drug Application as a complete, class 2 response to the FDA's action letter, with an indicated Prescription Drug User Fee Act goal date of December 21, 2012. Shares -2.5% AH.